The issue of omission of adjuvant radiation therapy for HER2+ BC was hypothesized several years ago by Dr. Bellon27, but radiation therapy continuously contributes, in a multidisciplinary context, to modify the natural history and management of the disease28. The gene discussed is ERBB2; the disease is breast cancer.